CAREY STEPHEN P.
SEC CIK 1674236 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ANIP | ANI PHARMACEUTICALS INC | SVP, CFO | 171.8K | — | $8.41M | 41 | 2022-03-23 | 2026-08-31 |
Most active insiders at ANIP, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Lalwani Nikhil | Pres, CEO, Dir | — | $5.05M |
| 2 | Walsh Patrick D | Dir | — | $2.32M |
| 3 | CAREY STEPHEN P. | SVP, CFO | — | $1.78M |
| 4 | Mutz Christopher | HEAD OF RARE DISEASE | — | $1.64M |
| 5 | Gassert Chad | SVP - CORP. DEV, STRATEGY | — | $1.31M |
| 6 | Davis Krista | SVP, Chief HR Off | — | $918.6K |
| 7 | Gutwerg Ori | SVP, GENERICS | — | $621.4K |
| 8 | Cook Meredith | SVP, GC, SEC | — | $453.9K |
| 9 | Rowland Thomas Andrew | SVP, HEAD - ESTABLISHED BRANDS | — | $393.8K |
| 10 | HAUGHEY THOMAS | Dir | — | $161.8K |
Transactions 41
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-09-01 18:18 | 2026-08-31 | ANIP | ANI PHARMACEUTICALS INC | CAREY STEPHEN P. | SVP, CFO | S - Sale | $72.80 | -2,850 | 171.8K | -2% | -$207.5K |
| T | 2026-07-30 16:02 | 2026-07-29 | ANIP | ANI PHARMACEUTICALS INC | CAREY STEPHEN P. | SVP, CFO | S - Sale | $81.36 | -2,850 | 174.7K | -2% | -$231.9K |
| DT | 2026-07-06 21:40 | 2026-07-02 | ANIP | ANI PHARMACEUTICALS INC | CAREY STEPHEN P. | SVP, CFO | M - OptEx | $49.51 | +3,313 | 180.9K | +2% | +$164.0K |
| DT | 2026-07-06 21:40 | 2026-07-02 | ANIP | ANI PHARMACEUTICALS INC | CAREY STEPHEN P. | SVP, CFO | S - Sale+OE | $86.00 | -3,313 | 177.5K | -2% | -$284.9K |
| T | 2026-06-30 16:14 | 2026-06-29 | ANIP | ANI PHARMACEUTICALS INC | CAREY STEPHEN P. | SVP, CFO | S - Sale | $84.12 | -2,850 | 177.5K | -2% | -$239.7K |
| DT | 2026-06-09 18:33 | 2026-06-05 | ANIP | ANI PHARMACEUTICALS INC | CAREY STEPHEN P. | SVP, CFO | M - OptEx | $49.51 | +3,312 | 183.7K | +2% | +$164.0K |
| DT | 2026-06-09 18:33 | 2026-06-05 | ANIP | ANI PHARMACEUTICALS INC | CAREY STEPHEN P. | SVP, CFO | S - Sale+OE | $80.00 | -3,312 | 180.4K | -2% | -$265.0K |
| 2026-03-10 | 2026-03-07 | ANIP | ANI PHARMACEUTICALS INC | CAREY STEPHEN P. | SVP, CFO | F - Tax | $74.04 | -5,150 | 180.4K | -3% | -$381.3K | |
| DM | 2026-03-05 | 2026-03-05 | ANIP | ANI PHARMACEUTICALS INC | CAREY STEPHEN P. | SVP, CFO | S - Sale+OE | $75.50 | -7,312 | 189.5K | -4% | -$552.0K |
| D | 2026-03-05 | 2026-03-05 | ANIP | ANI PHARMACEUTICALS INC | CAREY STEPHEN P. | SVP, CFO | M - OptEx | $49.51 | +3,312 | 192.9K | +2% | +$164.0K |
| 2026-03-02 | 2026-02-28 | ANIP | ANI PHARMACEUTICALS INC | CAREY STEPHEN P. | SVP, CFO | F - Tax | $73.90 | -2,773 | 189.5K | -1% | -$204.9K | |
| 2026-03-02 | 2026-02-26 | ANIP | ANI PHARMACEUTICALS INC | CAREY STEPHEN P. | SVP, CFO | A - Grant | $77.15 | +22.2K | 192.3K | +13% | +$1.72M | |
| M | 2026-02-17 | 2026-02-12+ | ANIP | ANI PHARMACEUTICALS INC | CAREY STEPHEN P. | SVP, CFO | F - Tax | $77.01 | -5,277 | 172.5K | -3% | -$406.4K |
| 2026-02-13 | 2026-02-11 | ANIP | ANI PHARMACEUTICALS INC | CAREY STEPHEN P. | SVP, CFO | F - Tax | $76.25 | -5,503 | 175.4K | -3% | -$419.6K | |
| D | 2025-08-14 | 2025-08-12 | ANIP | ANI PHARMACEUTICALS INC | CAREY STEPHEN P. | SVP, CFO | M - OptEx | $46.49 | +50.0K | 230.9K | +28% | +$2.32M |
| D | 2025-08-14 | 2025-08-12 | ANIP | ANI PHARMACEUTICALS INC | CAREY STEPHEN P. | SVP, CFO | S - Sale+OE | $86.07 | -50.0K | 180.9K | -22% | -$4.30M |
| 2025-03-25 | 2025-03-23 | ANIP | ANI PHARMACEUTICALS INC | CAREY STEPHEN P. | SVP, CFO | F - Tax | $64.26 | -6,210 | 180.9K | -3% | -$399.1K | |
| 2025-03-14 | 2025-03-07 | ANIP | ANI PHARMACEUTICALS INC | CAREY STEPHEN P. | SVP, CFO | F - Tax | $60.62 | -5,150 | 187.1K | -3% | -$312.2K | |
| 2025-03-04 | 2025-02-28 | ANIP | ANI PHARMACEUTICALS INC | CAREY STEPHEN P. | SVP, CFO | F - Tax | $61.89 | -1,861 | 192.2K | -1.0% | -$115.2K | |
| M | 2025-02-18 | 2025-02-12 | ANIP | ANI PHARMACEUTICALS INC | CAREY STEPHEN P. | SVP, CFO | A - Grant | $0.00 | +41.3K | 195.8K | +27% | $0 |
| 2025-02-18 | 2025-02-14 | ANIP | ANI PHARMACEUTICALS INC | CAREY STEPHEN P. | SVP, CFO | F - Tax | $58.92 | -1,730 | 194.1K | -0.9% | -$101.9K | |
| 2024-12-18 | 2024-12-17 | ANIP | ANI PHARMACEUTICALS INC | CAREY STEPHEN P. | SVP, CFO | S - Sale | $55.79 | -7,500 | 154.5K | -5% | -$418.4K | |
| 2024-06-06 | 2024-06-04 | ANIP | ANI PHARMACEUTICALS INC | CAREY STEPHEN P. | SVP, CFO | S - Sale | $63.58 | -5,000 | 162.0K | -3% | -$317.9K | |
| 2024-04-11 | 2024-04-10 | ANIP | ANI PHARMACEUTICALS INC | CAREY STEPHEN P. | SVP, CFO | F - Tax | $66.96 | -4,534 | 167.0K | -3% | -$303.6K | |
| 2024-03-25 | 2024-03-23 | ANIP | ANI PHARMACEUTICALS INC | CAREY STEPHEN P. | SVP, CFO | F - Tax | $69.58 | -6,210 | 171.5K | -3% | -$432.1K | |
| 2024-03-11 | 2024-03-11 | ANIP | ANI PHARMACEUTICALS INC | CAREY STEPHEN P. | SVP, CFO | S - Sale | $65.55 | -7,787 | 177.7K | -4% | -$510.4K | |
| 2024-03-11 | 2024-03-07 | ANIP | ANI PHARMACEUTICALS INC | CAREY STEPHEN P. | SVP, CFO | F - Tax | $66.71 | -4,216 | 185.5K | -2% | -$281.2K | |
| 2024-03-01 | 2024-02-29 | ANIP | ANI PHARMACEUTICALS INC | CAREY STEPHEN P. | SVP, CFO | F - Tax | $67.67 | -1,914 | 189.7K | -1.0% | -$129.5K | |
| M | 2024-02-16 | 2024-02-14 | ANIP | ANI PHARMACEUTICALS INC | CAREY STEPHEN P. | SVP, CFO | A - Grant | $0.00 | +35.8K | 177.3K | +25% | $0 |
| 2023-08-16 | 2023-08-14 | ANIP | ANI PHARMACEUTICALS INC | CAREY STEPHEN P. | SVP, CFO | S - Sale | $61.37 | -17.6K | 155.8K | -10% | -$1.08M | |
| 2023-04-12 | 2023-04-10 | ANIP | ANI PHARMACEUTICALS INC | CAREY STEPHEN P. | SVP, CFO | F - Tax | $38.50 | -4,534 | 173.5K | -3% | -$174.6K | |
| M | 2023-04-06 | 2023-02-28 | ANIP | ANI PHARMACEUTICALS INC | CAREY STEPHEN P. | SVP, CFO | A - Grant | $0.00 | +40.5K | 178.0K | +29% | $0 |
| 2023-03-30 | 2023-03-28 | ANIP | ANI PHARMACEUTICALS INC | CAREY STEPHEN P. | SVP AND CFO | F - Tax | $38.62 | -1,420 | 137.5K | -1% | -$54.8K | |
| 2023-03-27 | 2023-03-23 | ANIP | ANI PHARMACEUTICALS INC | CAREY STEPHEN P. | SVP AND CFO | F - Tax | $37.82 | -4,224 | 138.9K | -3% | -$159.8K | |
| M | 2023-03-09 | 2023-03-07 | ANIP | ANI PHARMACEUTICALS INC | CAREY STEPHEN P. | SVP AND CFO | F - Tax | $44.23 | -3,503 | 143.1K | -2% | -$154.9K |
| 2022-04-29 | 2022-04-27 | ANIP | ANI PHARMACEUTICALS INC | CAREY STEPHEN P. | SVP AND CFO | A - Grant | $0.00 | +11.3K | 146.6K | +8% | $0 | |
| 2022-04-12 | 2022-04-10 | ANIP | ANI PHARMACEUTICALS INC | CAREY STEPHEN P. | SVP AND CFO | F - Tax | $29.91 | -4,534 | 135.3K | -3% | -$135.6K | |
| 2022-04-08 | 2022-04-06 | ANIP | ANI PHARMACEUTICALS INC | CAREY STEPHEN P. | SVP AND CFO | F - Tax | $29.69 | -912 | 139.9K | -0.6% | -$27.1K | |
| 2022-03-30 | 2022-03-28 | ANIP | ANI PHARMACEUTICALS INC | CAREY STEPHEN P. | SVP AND CFO | F - Tax | $28.17 | -1,420 | 140.8K | -1.0% | -$40.0K | |
| 2022-03-28 | 2022-03-24 | ANIP | ANI PHARMACEUTICALS INC | CAREY STEPHEN P. | SVP AND CFO | A - Grant | $0.00 | +33.9K | 142.2K | +31% | $0 | |
| 2022-03-25 | 2022-03-23 | ANIP | ANI PHARMACEUTICALS INC | CAREY STEPHEN P. | SVP AND CFO | F - Tax | $27.03 | -4,167 | 108.3K | -4% | -$112.6K |
Purchase Sale Sale after option exercise All abbreviations